Search Results for: AC Immune SA to Receive
Articles
Merck & Ablynx Sign Global Agreement February 12, 2014
Ablynx recently announced it has entered into a second research collaboration and licensing agreement with a subsidiary of Merck &...EXECUTIVE INTERVIEW - Battelle: Innovation in Drug Delivery Through Integrated Science & Engineering January 7, 2014
Drug Development Executive: Amy Heintz, PhD, Senior Research Scientist at Battelle, speaks about the company’s relationship with customers and the importance of integrating device design, formulation, and human factors in the development of safe and efficient drug delivery solutions.
Avalon Ventures-GlaxoSmithKline Launch Sitari Pharm December 2, 2013
Avalon Ventures recently announced the launch of Sitari Pharmaceuticals, the first company formed by Avalon and GlaxoSmithKline (GSK) under a...Baxter International & Cell Therapeutics Announce Worldwide Strategic Collaboration November 19, 2013
Baxter International Inc. and Cell Therapeutics, Inc. recently announced they have entered into an exclusive worldwide licensing agreement to develop...Stallergenes & DBV Technologies Announce $198-Million Deal October 21, 2013
Stallergenes S.A., and DBV Technologies recently announced they have entered into a research and development agreement for the treatment of...INTRADERMAL DELIVERY - Advances in Intradermal Drug Delivery October 16, 2013
Zach Marks, MS, RPh, believes efficiency of vaccine use will be critical as the world population continues to grow and vaccine prices continue to rise, and ID administration can help reduce dose cost while potentially improving immunogenicity in traditional and hard-to-treat populations.
Roche & Inovio Enter $422.5-Million Licensing Deal September 18, 2013
Roche and Inovio Pharmaceuticals, Inc. recently announced they have entered into an exclusive worldwide license agreement to research, develop and...Ensemble Therapeutics Forms Global Strategic Collaboration With Novartis August 11, 2013
Ensemble Therapeutics recently announced the initiation of a two-part research and development collaboration with Novartis. The companies have entered into...SPECIAL FEATURE - Transdermal, Topical & Subcutaneous Drug Delivery: Extending Pipelines & Improving Self-Administration July 20, 2013
Contributor Cindy H. Dubin explores how the movement of home care and self- administration is pushing the development of this growing sector in drug delivery.
Immunocore & GSK in Potential $500-Million Plus Deal July 15, 2013
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs called ImmTACs to treat cancer and viral disease, recently announced...AUTOLOGOUS CELL THERAPIES - Development of Autologous Cell Therapies: Keys to Clinical & Commercial Success April 30, 2013
Ronnda L. Bartel, PhD, Tod Borton, and Brian S. Hampson review how Aastrom Biosciences has developed the innovative processes necessary to reduce risk throughout the manufacturing process. The company is now preparing for future commercialization for its investigational therapy derived from a patient’s own bone marrow stem cells.
INNOVATION AWARDS - Drug Delivery Award Winners Move Innovation Needle; Formulation Takes Center Stage March 31, 2013
Marc Dresner presents the three companies that were honored by their industry peers with prestigious awards for breakthrough drug delivery innovation at the Institute for International Research’s 17th annual Drug Delivery Partnerships conference.
3/6/2013 February 28, 2013
Capsugel Announces Major Acquisition Capsugel recently announced it has acquired Encap Drug Delivery. Based in Scotland, Encap's focus on liquid and...2/13/2013 February 11, 2013
Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential...Lycera Expands Partnership With Merck; Potential $600-Million Deal February 11, 2013
Lycera Corp. recently announced a collaboration agreement with Merck to discover, develop, and commercialize small-molecule therapies directed to selected...2/6/2013 January 31, 2013
Foresite Capital Closes $100 Million Fund for Late-Stage Biotechs Biotech venture capital isn't what it used to be, but there's...1/23/2012 January 21, 2013
Amgen Invests $200 Million in Monoclonal Antibodies Amgen recently announced plans to build a new manufacturing facility in the Tuas...1/9/2013 January 3, 2013
Ultragenyx Secures $75 Million for Ultra-Rare Diseases Ultragenyx Pharmaceutical Inc. recently announced the successful completion of a $75-million Series B...12/19/2012 December 13, 2012
Biogen Idec & Eisai Inc. Form Strategic Alliance Biogen Idec and Eisai Inc. recently announced a strategic alliance that will...12/5/2012 November 29, 2012
Curis Announces Several Major Announcements Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group,...
